{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:48:47Z","timestamp":1787068127906,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.jaci.2008.10.034","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T07:16:32Z","timestamp":1228979792000},"page":"895-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"123","author":[{"given":"Ozge Uysal","family":"Soyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"Aytac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayfer","family":"Tuncer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mualla","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Yetgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent Enis","family":"Sekerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2008.10.034_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0169-409X(03)00110-8","article-title":"Pegaspargase: a review of clinical studies","volume":"55","author":"Graham","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jaci.2008.10.034_bib2","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1517\/14656566.8.12.1977","article-title":"PEG-asparaginase","volume":"8","author":"Fu","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaci.2008.10.034_bib3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/sj.leu.2401162","article-title":"Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia","volume":"12","author":"Woo","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2008.10.034_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.critrevonc.2006.07.009","article-title":"Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia","volume":"61","author":"Narta","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaci.2008.10.034_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3476(70)80023-3","article-title":"Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia","volume":"77","author":"Pratt","year":"1970","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2008.10.034_bib6","first-page":"99","article-title":"Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement","volume":"8","author":"Cheung","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaci.2008.10.034_bib7","first-page":"406","article-title":"Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia","volume":"121","author":"Pratt","year":"1971","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2008.10.034_bib8","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/0006-2952(69)90375-X","article-title":"L-asparaginase resistance in human leukemia\u2014asparagine synthetase","volume":"18","author":"Haskell","year":"1969","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaci.2008.10.034_bib9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/sj.leu.2403351","article-title":"Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia","volume":"18","author":"Hak","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2008.10.034_bib10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.leu.2403011","article-title":"Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients","volume":"17","author":"Wang","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2008.10.034_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1097-0142(197002)25:2<306::AID-CNCR2820250206>3.0.CO;2-H","article-title":"E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children","volume":"25","author":"Tallal","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2008.10.034_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/1097-0142(197002)25:2<279::AID-CNCR2820250205>3.0.CO;2-7","article-title":"Clinical results of treatment with E coli L asparaginase in adults with leukemia, lymphoma, and solid tumors","volume":"25","author":"Clarkson","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2008.10.034_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-6749(98)70373-2","article-title":"Rapid desensitization for L-asparaginase hypersensitivity","volume":"101","author":"Bonno","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.10.034_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/08880010490277097","article-title":"The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse","volume":"21","author":"Unal","year":"2004","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaci.2008.10.034_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/mai.2001.119028","article-title":"Emergency department anaphylaxis: a review of 142 patients in a single year","volume":"108","author":"Brown","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.10.034_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2008.10.034_bib17","first-page":"942","article-title":"L-asparaginase in the treatment of neoplastic diseases in children","volume":"31","author":"Jaffe","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2008.10.034_bib18","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1200\/JCO.2000.18.7.1525","article-title":"Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia","volume":"18","author":"Woo","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaci.2008.10.034_bib19","first-page":"9","article-title":"Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia","volume":"1","author":"Nesbit","year":"1979","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaci.2008.10.034_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1097-0142(19920701)70:1<201::AID-CNCR2820700131>3.0.CO;2-M","article-title":"Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase","volume":"70","author":"Billett","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2008.10.034_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.leu.2401007","article-title":"Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia","volume":"12","author":"Larson","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2008.10.034_bib22","unstructured":"US Food and Drug Administration. FDA approves oncaspar for newly diagnosed acute lymphoblastic leukemia. 2006. Available at: www.fda.gov\/bbs\/topics\/NEWS\/2006\/NEW01419.html. Accessed November 25, 2008."},{"key":"10.1016\/j.jaci.2008.10.034_bib23","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.1993.11.9.1780","article-title":"Comparative pharmacokinetic studies of three asparaginase preparations","volume":"11","author":"Asselin","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaci.2008.10.034_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","article-title":"Use of L-asparaginase in childhood ALL","volume":"28","author":"M\u00fcller","year":"1998","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaci.2008.10.034_bib25","first-page":"23","article-title":"Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies","volume":"138","author":"K\u00f6rholz","year":"1990","journal-title":"Monatsschr Kinderheilkd"},{"key":"10.1016\/j.jaci.2008.10.034_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1203\/00006450-198519040-00017","article-title":"Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children\u2014evidence of a complement-mediated mechanism","volume":"19","author":"Fabry","year":"1985","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaci.2008.10.034_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/1097-0142(197601)37:1<220::AID-CNCR2820370132>3.0.CO;2-W","article-title":"Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia","volume":"37","author":"Killander","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2008.10.034_bib28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/pbc.20064","article-title":"Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia","volume":"43","author":"Zalewska-Szewczyk","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaci.2008.10.034_bib29","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/10428190701292049","article-title":"The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia","volume":"48","author":"Zalewska-Szewczyk","year":"2007","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674908019167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674908019167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:17:45Z","timestamp":1758788265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674908019167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0091674908019167"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2008.10.034","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2008.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}